Structure and Vibrational Spectroscopy of C82 Fullerenol Valent Isomers: An Experimental and Theoretical Joint Study
- PMID: 36838557
- PMCID: PMC9965979
- DOI: 10.3390/molecules28041569
Structure and Vibrational Spectroscopy of C82 Fullerenol Valent Isomers: An Experimental and Theoretical Joint Study
Abstract
Gd@C82OxHy endohedral complexes for advanced biomedical applications (computer tomography, cancer treatment, etc.) were synthesized using high-frequency arc plasma discharge through a mixture of graphite and Gd2O3 oxide. The Gd@C82 endohedral complex was isolated by high-efficiency liquid chromatography and consequently oxidized with the formation of a family of Gd endohedral fullerenols with gross formula Gd@C82O8(OH)20. Fourier-transformed infrared (FTIR) spectroscopy was used to study the structure and spectroscopic properties of the complexes in combination with the DFTB3 electronic structure calculations and infrared spectra simulations. It was shown that the main IR spectral features are formed by a fullerenole C82 cage that allows one to consider the force constants at the DFTB3 level of theory without consideration of gadolinium endohedral ions inside the carbon cage. Based on the comparison of experimental FTIR and theoretical DFTB3 IR spectra, it was found that oxidation of the C82 cage causes the formation of Gd@C82O28H20, with a breakdown of the integrity of the parent C82 cage with the formation of pores between neighboring carbonyl and carboxyl groups. The Gd@C82O6(OOH)2(OH)18 endohedral complex with epoxy, carbonyl and carboxyl groups was considered the most reliable fullerenole structural model.
Keywords: C82; DFTB3 electronic structure calculations; Gd endohedral complexes; IR spectra; biomedical applications; fullerenols.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Gd@C82 Fullerenol.2008 Oct 31 [updated 2008 Dec 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Oct 31 [updated 2008 Dec 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641737 Free Books & Documents. Review.
-
Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.J Nanosci Nanotechnol. 2010 Dec;10(12):8610-6. doi: 10.1166/jnn.2010.2691. J Nanosci Nanotechnol. 2010. PMID: 21121373 Free PMC article.
-
Metallofullerenol Gd@C82(OH)22 preserves human erythrocyte plasma membrane integrity from AAPH-induced oxidative stress: Molecular mechanisms and antioxidant activity.Free Radic Biol Med. 2025 Mar 1;229:499-513. doi: 10.1016/j.freeradbiomed.2025.01.052. Epub 2025 Jan 26. Free Radic Biol Med. 2025. PMID: 39875061
-
Does Gd@C82 have an anomalous endohedral structure? Synthesis and single crystal X-ray structure of the carbene adduct.J Am Chem Soc. 2008 Oct 1;130(39):12840-1. doi: 10.1021/ja802156n. Epub 2008 Sep 9. J Am Chem Soc. 2008. PMID: 18778060
-
Tri-gadolinium nitride PEGylated-hydroxylated endohedral metallofullerene.2008 Oct 28 [updated 2008 Dec 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Oct 28 [updated 2008 Dec 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641442 Free Books & Documents. Review.
Cited by
-
Effects of Endohedral Gd-Containing Fullerenols with a Different Number of Oxygen Substituents on Bacterial Bioluminescence.Int J Mol Sci. 2024 Jan 5;25(2):708. doi: 10.3390/ijms25020708. Int J Mol Sci. 2024. PMID: 38255785 Free PMC article.
References
-
- Dostalova S., Moulick A., Milosavljevic V., Guran R., Kominkova M., Cihalova K., Heger Z., Blazkova L., Kopel P., Hynek D., et al. Antiviral Activity of Fullerene C60 Nanocrystals Modified with Derivatives of Anionic Antimicrobial Peptide Maximin H5. Mon. Chem. Chem. Mon. 2016;147:905–918. doi: 10.1007/s00706-016-1675-0. - DOI
-
- Sergeeva V., Kraevaya O., Ershova E., Kameneva L., Malinovskaya E., Dolgikh O., Konkova M., Voronov I., Zhilenkov A., Veiko N., et al. Antioxidant Properties of Fullerene Derivatives Depend on Their Chemical Structure: A Study of Two Fullerene Derivatives on HELFs. Oxidative Med. Cell. Longev. 2019;2019:4398695. doi: 10.1155/2019/4398695. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources